The Conference on Retroviruses and Opportunistic Infections is regarded as one of the most important HIV/AIDS scientific gatherings of the year. More than 3,200 clinicians and basic scientists come from around the world to present the latest research on HIV/AIDS and opportunistic infections. The meeting is sponsored by the Foundation for Retrovirology and Human Health and is in scientific collaboration with the National Institute of Allergy and Infectious Diseases and the Centers for Disease Control and Prevention.
Funding for coverage of this conference is provided, in part, by unrestricted educational grants from Abbott Laboratories, Boehringer Ingelheim, Bristol-Myers Squibb, GlaxoSmithKline, Roche Laboratories and Trimeris.
Please note: Knowledge about HIV changes rapidly. Note the date of this summary's publication, and before treating patients or employing any therapies described in these materials, verify all information independently. If you are a patient, please consult a doctor or other medical professional before acting on any of the information presented in this summary. For a complete listing of our most recent conference coverage, click here.
